Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT

BACKGROUND: The randomized, placebo-controlled COLCOT (Colchicine Cardiovascular Outcomes Trial) has shown the benefits of colchicine 0.5 mg daily to lower the rate of ischemic cardiovascular events in patients with a recent myocardial infarction. Here, we conducted a post hoc pharmacogenomic study...

詳細記述

保存先:
書誌詳細
出版年:Circ Genom Precis Med
主要な著者: Dubé, Marie-Pierre, Legault, Marc-André, Lemaçon, Audrey, Lemieux Perreault, Louis-Philippe, Fouodjio, René, Waters, David D., Kouz, Simon, Pinto, Fausto J., Maggioni, Aldo P., Diaz, Rafael, Berry, Colin, Koenig, Wolfgang, Lopez-Sendon, Jose, Gamra, Habib, Kiwan, Ghassan S., Asselin, Géraldine, Provost, Sylvie, Barhdadi, Amina, Sun, Maxine, Cossette, Mariève, Blondeau, Lucie, Mongrain, Ian, Dubois, Anick, Rhainds, David, Bouabdallaoui, Nadia, Samuel, Michelle, de Denus, Simon, L’Allier, Philippe L., Guertin, Marie-Claude, Roubille, François, Tardif, Jean-Claude
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2021
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284376/
https://ncbi.nlm.nih.gov/pubmed/33560138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.120.003183
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料